Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study

Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study

Background: The most beneficial neoadjuvant chemoradiotherapy (nCRT) combination for esophageal squamous cell carcinoma (ESCC) in Asia remains uncertain. Herein, we compared the neoadjuvant carboplatin/paclitaxel (CROSS) regimen versus the cisplatin/5-fluorouracil (PF) regimen in combination with 41...

Full description

Bibliographic Details
Main Authors: Xing Gao, Ping-Chung Tsai, Kai-Hao Chuang, Chu-Pin Pai, Po-Kuei Hsu, Shau-Hsuan Li, Hung-I Lu, Joseph Jan-Baptist van Lanschot, Yin-Kai Chao
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cancers
Subjects:
esophageal cancer
esophageal squamous cell carcinoma
neoadjuvant
chemoradiotherapy
Online Access:https://www.mdpi.com/2072-6694/14/11/2610

Internet

https://www.mdpi.com/2072-6694/14/11/2610

Similar Items